Literature DB >> 23917744

Mucopolysaccharidosis type I and craniosynostosis.

Jawad Ziyadeh1, Martine Le Merrer, Matthieu Robert, Eric Arnaud, Vassili Valayannopoulos, Federico Di Rocco.   

Abstract

Mucopolysaccharidosis type-I is caused by a deficiency of the lysosomal enzyme α-L-iduronidase, resulting in gradual deposition of glycosaminoglycans in multiple body organs, affecting physical appearance and system functioning. We present the first reported case associating MPS-I (Hurler-Scheie subtype) with craniosynostosis. A 2.5-year-old girl presented initially with macrocrania. On clinical and radiological examinations we noted a scaphocephaly with dysmorphic facial features of MPS confirmed later on. Intracranial hypertension was documented at fundoscopy (papilloedema) and ICP monitoring, and then surgically treated. This association of scaphocephaly and MPS-I highlights the importance of a meticulous physical examination performed by craniofacial, metabolic and ophthalmologic teams.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23917744     DOI: 10.1007/s00701-013-1831-9

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  2 in total

Review 1.  Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses.

Authors:  Carlton R Fenzl; Kyla Teramoto; Majid Moshirfar
Journal:  Clin Ophthalmol       Date:  2015-09-07

2.  Craniosynostosis affects the majority of mucopolysaccharidosis patients and can contribute to increased intracranial pressure.

Authors:  Esmee Oussoren; Irene M J Mathijssen; Margreet Wagenmakers; Rob M Verdijk; Hansje H Bredero-Boelhouwer; Marie-Lise C van Veelen-Vincent; Jan C van der Meijden; Johanna M P van den Hout; George J G Ruijter; Ans T van der Ploeg; Mirjam Langeveld
Journal:  J Inherit Metab Dis       Date:  2018-08-06       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.